

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.68278622 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.68278622 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.44832099 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.44832099 |
| 5 | complement activation, alternative pathway (GO:0006957) | 6.09566440 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.94187174 |
| 7 | regulation of protein activation cascade (GO:2000257) | 5.81114986 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.80421159 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 5.78969697 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 5.73552042 |
| 11 | omega-hydroxylase P450 pathway (GO:0097267) | 5.60325909 |
| 12 | regulation of complement activation (GO:0030449) | 5.49847208 |
| 13 | protein carboxylation (GO:0018214) | 5.44103649 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.44103649 |
| 15 | regulation of fibrinolysis (GO:0051917) | 5.38757215 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.34664899 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 5.34664899 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 5.34664899 |
| 19 | urea cycle (GO:0000050) | 5.33565041 |
| 20 | urea metabolic process (GO:0019627) | 5.33565041 |
| 21 | kynurenine metabolic process (GO:0070189) | 5.25124827 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.24438559 |
| 23 | bile acid biosynthetic process (GO:0006699) | 5.21923974 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.13635268 |
| 25 | glyoxylate metabolic process (GO:0046487) | 5.12757905 |
| 26 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.00487379 |
| 27 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.00487379 |
| 28 | tryptophan metabolic process (GO:0006568) | 5.00484453 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.93653462 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.92331002 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.90017106 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.71146375 |
| 33 | cysteine metabolic process (GO:0006534) | 4.70733417 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69837483 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.51144563 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.51144563 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.51144563 |
| 38 | triglyceride homeostasis (GO:0070328) | 4.49882886 |
| 39 | acylglycerol homeostasis (GO:0055090) | 4.49882886 |
| 40 | bile acid metabolic process (GO:0008206) | 4.44229298 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.39486707 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.39420061 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.36596484 |
| 44 | plasma lipoprotein particle clearance (GO:0034381) | 4.32574954 |
| 45 | phospholipid efflux (GO:0033700) | 4.27769887 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.26472835 |
| 47 | acute-phase response (GO:0006953) | 4.24188113 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.22216400 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 4.20716309 |
| 50 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.18301853 |
| 51 | protein activation cascade (GO:0072376) | 4.17011415 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.16457538 |
| 53 | lysine catabolic process (GO:0006554) | 4.10116840 |
| 54 | lysine metabolic process (GO:0006553) | 4.10116840 |
| 55 | complement activation (GO:0006956) | 4.07752029 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.06748973 |
| 57 | fibrinolysis (GO:0042730) | 4.06192252 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.04142120 |
| 59 | drug metabolic process (GO:0017144) | 4.03152665 |
| 60 | complement activation, classical pathway (GO:0006958) | 4.00018211 |
| 61 | opsonization (GO:0008228) | 3.99576097 |
| 62 | detection of other organism (GO:0098543) | 3.96485068 |
| 63 | detection of external biotic stimulus (GO:0098581) | 3.95464739 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.92286313 |
| 65 | negative regulation of sterol transport (GO:0032372) | 3.92286313 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.90152684 |
| 67 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89701388 |
| 68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89701388 |
| 69 | detection of bacterium (GO:0016045) | 3.88997392 |
| 70 | cholesterol efflux (GO:0033344) | 3.88489033 |
| 71 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.86484626 |
| 72 | negative regulation of B cell mediated immunity (GO:0002713) | 3.86484626 |
| 73 | negative regulation of complement activation (GO:0045916) | 3.84820650 |
| 74 | bile acid and bile salt transport (GO:0015721) | 3.84314048 |
| 75 | acute inflammatory response (GO:0002526) | 3.83687708 |
| 76 | negative regulation of lipase activity (GO:0060192) | 3.80932637 |
| 77 | arginine metabolic process (GO:0006525) | 3.76241986 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 3.75971095 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.75143152 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 3.72375198 |
| 81 | blood coagulation, intrinsic pathway (GO:0007597) | 3.72082738 |
| 82 | oxidative demethylation (GO:0070989) | 3.71920086 |
| 83 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.71424606 |
| 84 | negative regulation of humoral immune response (GO:0002921) | 3.70693366 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 3.69992715 |
| 86 | indolalkylamine metabolic process (GO:0006586) | 3.68960373 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.65351855 |
| 88 | plasma lipoprotein particle assembly (GO:0034377) | 3.64021913 |
| 89 | ethanol oxidation (GO:0006069) | 3.61506542 |
| 90 | drug catabolic process (GO:0042737) | 3.61103075 |
| 91 | glutamate metabolic process (GO:0006536) | 3.60479231 |
| 92 | cellular biogenic amine catabolic process (GO:0042402) | 3.59967450 |
| 93 | amine catabolic process (GO:0009310) | 3.59967450 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.59956715 |
| 95 | cytolysis (GO:0019835) | 3.59469624 |
| 96 | uronic acid metabolic process (GO:0006063) | 3.58594799 |
| 97 | glucuronate metabolic process (GO:0019585) | 3.58594799 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.58361232 |
| 99 | negative regulation of protein activation cascade (GO:2000258) | 3.56890620 |
| 100 | glycine metabolic process (GO:0006544) | 3.56880888 |
| 101 | cholesterol homeostasis (GO:0042632) | 3.54509583 |
| 102 | heme transport (GO:0015886) | 3.50816288 |
| 103 | cellular modified amino acid catabolic process (GO:0042219) | 3.50429503 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 3.49234912 |
| 105 | modulation by symbiont of host defense response (GO:0052031) | 3.49234912 |
| 106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.49234912 |
| 107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.49234912 |
| 108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.49234912 |
| 109 | modulation by symbiont of host immune response (GO:0052553) | 3.49234912 |
| 110 | sterol homeostasis (GO:0055092) | 3.48950898 |
| 111 | negative regulation of cell killing (GO:0031342) | 3.48003430 |
| 112 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.48003430 |
| 113 | regulation of humoral immune response (GO:0002920) | 3.47329983 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.47225760 |
| 115 | serine family amino acid metabolic process (GO:0009069) | 3.46831148 |
| 116 | regulation of acute inflammatory response (GO:0002673) | 3.46559427 |
| 117 | alkaloid metabolic process (GO:0009820) | 3.46551560 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.46348072 |
| 119 | detection of biotic stimulus (GO:0009595) | 3.45657477 |
| 120 | cellular glucuronidation (GO:0052695) | 3.43692553 |
| 121 | exogenous drug catabolic process (GO:0042738) | 3.42261221 |
| 122 | aldehyde catabolic process (GO:0046185) | 3.39882536 |
| 123 | low-density lipoprotein particle remodeling (GO:0034374) | 3.39413673 |
| 124 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.39363684 |
| 125 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.38493072 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 3.38327604 |
| 127 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.36943394 |
| 128 | ethanol metabolic process (GO:0006067) | 3.36064848 |
| 129 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.36002661 |
| 130 | cofactor catabolic process (GO:0051187) | 3.33723792 |
| 131 | macrophage activation involved in immune response (GO:0002281) | 3.33531836 |
| 132 | carboxylic acid catabolic process (GO:0046395) | 3.32142658 |
| 133 | organic acid catabolic process (GO:0016054) | 3.32142658 |
| 134 | fatty acid oxidation (GO:0019395) | 3.30070895 |
| 135 | regulation of plasminogen activation (GO:0010755) | 3.29588880 |
| 136 | phenylpropanoid metabolic process (GO:0009698) | 3.28852407 |
| 137 | protein-lipid complex assembly (GO:0065005) | 3.28267331 |
| 138 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.22020161 |
| 139 | negative regulation of blood coagulation (GO:0030195) | 3.17350902 |
| 140 | negative regulation of hemostasis (GO:1900047) | 3.17350902 |
| 141 | positive regulation of blood coagulation (GO:0030194) | 3.15393730 |
| 142 | positive regulation of hemostasis (GO:1900048) | 3.15393730 |
| 143 | neutrophil activation involved in immune response (GO:0002283) | 3.14574225 |
| 144 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13697253 |
| 145 | flavonoid metabolic process (GO:0009812) | 3.11386567 |
| 146 | disruption of cells of other organism (GO:0044364) | 3.08851885 |
| 147 | killing of cells of other organism (GO:0031640) | 3.08851885 |
| 148 | regulation of apoptotic cell clearance (GO:2000425) | 3.01632403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.39742975 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.40741732 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.95788796 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.84071585 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.78854259 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.02239602 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.48190875 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74931393 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.29823623 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60524848 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28739843 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27658167 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14590678 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.13401298 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12181667 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03861051 |
| 17 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5949082 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85682858 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73659668 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69523174 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66636913 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64199591 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61472343 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.60376578 |
| 25 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.60023115 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57674198 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55935987 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50452438 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47731494 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47517631 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44662951 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43474433 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38121071 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36447792 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33446324 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33176599 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32520565 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32133560 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31696988 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30291355 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28528054 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.28148664 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25411064 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24271982 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24190167 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24001722 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22428294 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19563702 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17665450 |
| 50 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17248581 |
| 51 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14419645 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14400403 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13352462 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12074269 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.12034319 |
| 56 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10390318 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09618614 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09478084 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09295112 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.09054284 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08749053 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06240089 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05629874 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04374247 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03872218 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01796769 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01753228 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00567891 |
| 69 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.00306301 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00070303 |
| 71 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99967741 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99916975 |
| 73 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99722140 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98845250 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98758472 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98259734 |
| 77 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98255729 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98196648 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97596366 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97562656 |
| 81 | P300_27268052_Chip-Seq_Bcells_Human | 0.96498905 |
| 82 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94668044 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93435690 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92605498 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91774338 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90806362 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89770381 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89470744 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.88745550 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 0.88632368 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86822616 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.86012820 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85846159 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85656761 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85480194 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85465324 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.82225973 |
| 98 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82039982 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81497505 |
| 100 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81419552 |
| 101 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81384507 |
| 102 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81246452 |
| 103 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80395888 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80313307 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80253657 |
| 106 | ERA_21632823_ChIP-Seq_H3396_Human | 0.79720501 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78618147 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78534360 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78457320 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.75101362 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73481010 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.72278238 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72218372 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69530068 |
| 115 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.68582638 |
| 116 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.67821664 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66225644 |
| 118 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64939408 |
| 119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64936249 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64885326 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64739979 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64739979 |
| 123 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.64461676 |
| 124 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.64096378 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64079673 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.63297532 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62263392 |
| 128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.61717515 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61636159 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61500172 |
| 131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60955677 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.60891551 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59499265 |
| 134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.58466692 |
| 135 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58251545 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.57884846 |
| 137 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57000490 |
| 138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55810391 |
| 139 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.55209072 |
| 140 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.54722185 |
| 141 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.54722185 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.54182879 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51610693 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51265464 |
| 145 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51115585 |
| 146 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50911394 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50422410 |
| 148 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50343265 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50303822 |
| 150 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49681143 |
| 151 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49184700 |
| 152 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47781531 |
| 153 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.47759587 |
| 154 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.47670060 |
| 155 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.47529498 |
| 156 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.47360768 |
| 157 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.47360311 |
| 158 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.46369960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.81773938 |
| 2 | MP0005360_urolithiasis | 6.34737002 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.48006008 |
| 4 | MP0005365_abnormal_bile_salt | 5.30792737 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.18629211 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.49237435 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.42588095 |
| 8 | MP0009840_abnormal_foam_cell | 3.23371840 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.22219859 |
| 10 | MP0003252_abnormal_bile_duct | 3.17276600 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.97620310 |
| 12 | MP0003724_increased_susceptibility_to | 2.77241994 |
| 13 | MP0005083_abnormal_biliary_tract | 2.66786767 |
| 14 | MP0002132_abnormal_respiratory_system | 2.38920006 |
| 15 | MP0005332_abnormal_amino_acid | 2.38066839 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.20099307 |
| 17 | MP0000609_abnormal_liver_physiology | 2.16997717 |
| 18 | MP0003195_calcinosis | 2.05180589 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.04014587 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.03769319 |
| 21 | MP0001835_abnormal_antigen_presentation | 1.96586101 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.94271189 |
| 23 | MP0000685_abnormal_immune_system | 1.90995952 |
| 24 | MP0001790_abnormal_immune_system | 1.87802578 |
| 25 | MP0005387_immune_system_phenotype | 1.87802578 |
| 26 | MP0001800_abnormal_humoral_immune | 1.79934432 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.79860192 |
| 28 | MP0005670_abnormal_white_adipose | 1.74575173 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.67637121 |
| 30 | MP0006082_CNS_inflammation | 1.64644560 |
| 31 | MP0006054_spinal_hemorrhage | 1.63724362 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.63454546 |
| 33 | MP0002723_abnormal_immune_serum | 1.59991760 |
| 34 | MP0005671_abnormal_response_to | 1.58987389 |
| 35 | MP0001879_abnormal_lymphatic_vessel | 1.54851757 |
| 36 | MP0002277_abnormal_respiratory_mucosa | 1.46742295 |
| 37 | MP0008004_abnormal_stomach_pH | 1.45715674 |
| 38 | MP0001764_abnormal_homeostasis | 1.43881229 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43390030 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.41102567 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.41058376 |
| 42 | MP0004130_abnormal_muscle_cell | 1.41040940 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.40441189 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.35622792 |
| 45 | MP0001819_abnormal_immune_cell | 1.34943988 |
| 46 | MP0003868_abnormal_feces_composition | 1.34923336 |
| 47 | MP0009764_decreased_sensitivity_to | 1.31338579 |
| 48 | MP0003011_delayed_dark_adaptation | 1.29492695 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.28697853 |
| 50 | MP0009763_increased_sensitivity_to | 1.27117007 |
| 51 | MP0002254_reproductive_system_inflammat | 1.21965248 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.20633428 |
| 53 | MP0000598_abnormal_liver_morphology | 1.20475155 |
| 54 | MP0000604_amyloidosis | 1.20054549 |
| 55 | MP0003436_decreased_susceptibility_to | 1.18910304 |
| 56 | MP0002405_respiratory_system_inflammati | 1.18519070 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.16111539 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.14322637 |
| 59 | MP0003186_abnormal_redox_activity | 1.13461553 |
| 60 | MP0008469_abnormal_protein_level | 1.11255495 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 1.05698633 |
| 62 | MP0003866_abnormal_defecation | 1.05133861 |
| 63 | MP0005451_abnormal_body_composition | 1.05068252 |
| 64 | MP0000716_abnormal_immune_system | 0.97501271 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.97273084 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.96844698 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.96844698 |
| 68 | MP0005666_abnormal_adipose_tissue | 0.95219389 |
| 69 | MP0004947_skin_inflammation | 0.94253667 |
| 70 | MP0009697_abnormal_copulation | 0.93824065 |
| 71 | MP0001851_eye_inflammation | 0.93041230 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.92333482 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.92096345 |
| 74 | MP0002971_abnormal_brown_adipose | 0.91056036 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.90656840 |
| 76 | MP0003690_abnormal_glial_cell | 0.90280442 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.88951862 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.87561260 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.87441787 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.87268879 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.87137585 |
| 82 | MP0004510_myositis | 0.86563244 |
| 83 | MP0005647_abnormal_sex_gland | 0.85755023 |
| 84 | MP0003878_abnormal_ear_physiology | 0.84727797 |
| 85 | MP0005377_hearing/vestibular/ear_phenot | 0.84727797 |
| 86 | MP0003879_abnormal_hair_cell | 0.83472650 |
| 87 | MP0003075_altered_response_to | 0.81976744 |
| 88 | MP0002398_abnormal_bone_marrow | 0.81360683 |
| 89 | MP0003303_peritoneal_inflammation | 0.80102668 |
| 90 | MP0001661_extended_life_span | 0.79483144 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.78371470 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.77388391 |
| 93 | MP0000858_altered_metastatic_potential | 0.77065677 |
| 94 | MP0002722_abnormal_immune_system | 0.76142938 |
| 95 | MP0009278_abnormal_bone_marrow | 0.74809027 |
| 96 | MP0001663_abnormal_digestive_system | 0.74361127 |
| 97 | MP0005334_abnormal_fat_pad | 0.73980346 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.73796542 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.73560481 |
| 100 | MP0003828_pulmonary_edema | 0.72304482 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.71703800 |
| 102 | MP0005164_abnormal_response_to | 0.71360550 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.71301328 |
| 104 | MP0002928_abnormal_bile_duct | 0.71044308 |
| 105 | MP0008260_abnormal_autophagy | 0.70707834 |
| 106 | MP0000249_abnormal_blood_vessel | 0.70616851 |
| 107 | MP0002429_abnormal_blood_cell | 0.70514793 |
| 108 | MP0002796_impaired_skin_barrier | 0.67984631 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.66945914 |
| 110 | MP0002419_abnormal_innate_immunity | 0.66939994 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.64421345 |
| 112 | MP0004883_abnormal_blood_vessel | 0.62668974 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.62324900 |
| 114 | MP0005535_abnormal_body_temperature | 0.59911715 |
| 115 | MP0009785_altered_susceptibility_to | 0.59835846 |
| 116 | MP0005166_decreased_susceptibility_to | 0.59510495 |
| 117 | MP0000343_altered_response_to | 0.58861474 |
| 118 | MP0005025_abnormal_response_to | 0.58861132 |
| 119 | MP0005023_abnormal_wound_healing | 0.57881564 |
| 120 | MP0001881_abnormal_mammary_gland | 0.57821618 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.57326500 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.57058333 |
| 123 | MP0003329_amyloid_beta_deposits | 0.56846824 |
| 124 | MP0001756_abnormal_urination | 0.56621642 |
| 125 | MP0008874_decreased_physiological_sensi | 0.54951409 |
| 126 | MP0000465_gastrointestinal_hemorrhage | 0.54675714 |
| 127 | MP0005408_hypopigmentation | 0.52984128 |
| 128 | MP0001243_abnormal_dermal_layer | 0.52647105 |
| 129 | MP0002876_abnormal_thyroid_physiology | 0.52644242 |
| 130 | MP0008873_increased_physiological_sensi | 0.52435363 |
| 131 | MP0008438_abnormal_cutaneous_collagen | 0.51682570 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.50535214 |
| 133 | MP0005448_abnormal_energy_balance | 0.49582774 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.49375769 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.49361383 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.47670308 |
| 137 | MP0005084_abnormal_gallbladder_morpholo | 0.47582708 |
| 138 | MP0004272_abnormal_basement_membrane | 0.47557598 |
| 139 | MP0005220_abnormal_exocrine_pancreas | 0.47175297 |
| 140 | MP0009115_abnormal_fat_cell | 0.46537594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.62719853 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 6.43989558 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.39134738 |
| 4 | Complement deficiency (HP:0004431) | 6.29122502 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.23880090 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.02115713 |
| 7 | Xanthomatosis (HP:0000991) | 5.75382141 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.38481590 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.22866458 |
| 10 | Joint hemorrhage (HP:0005261) | 5.00967379 |
| 11 | Abnormality of complement system (HP:0005339) | 4.79065002 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.74806398 |
| 13 | Orchitis (HP:0100796) | 4.72125684 |
| 14 | Myositis (HP:0100614) | 4.67280304 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 4.55340994 |
| 16 | Optic neuritis (HP:0100653) | 4.55340994 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.43594556 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.41653904 |
| 19 | Eczematoid dermatitis (HP:0000976) | 4.37347389 |
| 20 | Hyperammonemia (HP:0001987) | 4.16830465 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14330763 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 4.07030685 |
| 23 | Recurrent abscess formation (HP:0002722) | 4.03516571 |
| 24 | Epidermoid cyst (HP:0200040) | 3.95963230 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.89866135 |
| 26 | Ketosis (HP:0001946) | 3.77243000 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.66801072 |
| 28 | Hyperglycinemia (HP:0002154) | 3.66521178 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61360641 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.54720360 |
| 31 | Nonimmune hydrops fetalis (HP:0001790) | 3.52869932 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.51725429 |
| 33 | Fat malabsorption (HP:0002630) | 3.51291551 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.49455106 |
| 35 | Stomatitis (HP:0010280) | 3.48165498 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 3.43824957 |
| 37 | Hyperglycinuria (HP:0003108) | 3.40599613 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.39284207 |
| 39 | Abnormality of macrophages (HP:0004311) | 3.37199351 |
| 40 | Spontaneous abortion (HP:0005268) | 3.35104481 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.33164766 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33164766 |
| 43 | Hypochromic anemia (HP:0001931) | 3.22771601 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21930975 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17348929 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.16340793 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16239918 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 3.13368399 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13040102 |
| 50 | Purpura (HP:0000979) | 3.10787505 |
| 51 | Glomerulonephritis (HP:0000099) | 3.06826204 |
| 52 | Meningitis (HP:0001287) | 3.06364696 |
| 53 | Amyloidosis (HP:0011034) | 3.04381369 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 3.03608641 |
| 55 | Gangrene (HP:0100758) | 3.01731347 |
| 56 | Keratoconjunctivitis (HP:0001096) | 3.00019619 |
| 57 | Myocardial infarction (HP:0001658) | 2.96525686 |
| 58 | Anorexia (HP:0002039) | 2.94785815 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.93467774 |
| 60 | Obstructive lung disease (HP:0006536) | 2.93467774 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92802291 |
| 62 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90687775 |
| 63 | Vascular calcification (HP:0004934) | 2.85234894 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.78237948 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.74055466 |
| 66 | Esophageal varix (HP:0002040) | 2.69836848 |
| 67 | Steatorrhea (HP:0002570) | 2.69739590 |
| 68 | Ketoacidosis (HP:0001993) | 2.67676139 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.66938831 |
| 70 | Skin nodule (HP:0200036) | 2.61486418 |
| 71 | Encephalitis (HP:0002383) | 2.60134598 |
| 72 | Joint swelling (HP:0001386) | 2.58174374 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.56501214 |
| 74 | Gingival bleeding (HP:0000225) | 2.56347821 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.50267574 |
| 76 | Abnormality of serum amino acid levels (HP:0003112) | 2.47543764 |
| 77 | Gout (HP:0001997) | 2.46611948 |
| 78 | Vasculitis (HP:0002633) | 2.45257871 |
| 79 | Thrombophlebitis (HP:0004418) | 2.45238309 |
| 80 | Recurrent skin infections (HP:0001581) | 2.44320120 |
| 81 | Gingivitis (HP:0000230) | 2.44186940 |
| 82 | Mediastinal lymphadenopathy (HP:0100721) | 2.42738456 |
| 83 | Arterial thrombosis (HP:0004420) | 2.40136372 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39881496 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 2.39881496 |
| 86 | Increased IgE level (HP:0003212) | 2.35546390 |
| 87 | Recurrent fungal infections (HP:0002841) | 2.34704203 |
| 88 | Metabolic acidosis (HP:0001942) | 2.34147725 |
| 89 | Hemoptysis (HP:0002105) | 2.33753707 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.32700729 |
| 91 | Mitral stenosis (HP:0001718) | 2.29741783 |
| 92 | Nephritis (HP:0000123) | 2.28022729 |
| 93 | Urticaria (HP:0001025) | 2.23214801 |
| 94 | Pulmonary infiltrates (HP:0002113) | 2.23131977 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 2.22579357 |
| 96 | Lethargy (HP:0001254) | 2.22520442 |
| 97 | Spastic diplegia (HP:0001264) | 2.21592357 |
| 98 | Prolonged bleeding time (HP:0003010) | 2.21559880 |
| 99 | Menorrhagia (HP:0000132) | 2.18813969 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 2.17724202 |
| 101 | Microcytic anemia (HP:0001935) | 2.17405027 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16990763 |
| 103 | Episodic fever (HP:0001954) | 2.16685915 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.16053024 |
| 105 | Cholecystitis (HP:0001082) | 2.16053024 |
| 106 | Irritability (HP:0000737) | 2.11651105 |
| 107 | Osteomalacia (HP:0002749) | 2.10960597 |
| 108 | Polycythemia (HP:0001901) | 2.10489372 |
| 109 | Neonatal onset (HP:0003623) | 2.08643924 |
| 110 | Cholelithiasis (HP:0001081) | 2.07922734 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 2.07694224 |
| 112 | Sensorimotor neuropathy (HP:0007141) | 2.07318275 |
| 113 | Hypoglycemic seizures (HP:0002173) | 2.06417093 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05396935 |
| 115 | Hypertriglyceridemia (HP:0002155) | 2.05072154 |
| 116 | Pancreatitis (HP:0001733) | 2.04561840 |
| 117 | Acne (HP:0001061) | 2.02644886 |
| 118 | Abnormality of the pleura (HP:0002103) | 1.99777260 |
| 119 | Pulmonary embolism (HP:0002204) | 1.98792495 |
| 120 | Malnutrition (HP:0004395) | 1.94523164 |
| 121 | Late onset (HP:0003584) | 1.89628385 |
| 122 | Vomiting (HP:0002013) | 1.89108864 |
| 123 | Cerebral edema (HP:0002181) | 1.87777277 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82464382 |
| 125 | Increased serum ferritin (HP:0003281) | 1.81984270 |
| 126 | Brushfield spots (HP:0001088) | 1.81964078 |
| 127 | Increased purine levels (HP:0004368) | 1.81233582 |
| 128 | Hyperuricemia (HP:0002149) | 1.81233582 |
| 129 | Hyperglycemia (HP:0003074) | 1.80896520 |
| 130 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80022134 |
| 131 | Spontaneous hematomas (HP:0007420) | 1.79057995 |
| 132 | Generalized aminoaciduria (HP:0002909) | 1.77991716 |
| 133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77070262 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77070262 |
| 135 | Rickets (HP:0002748) | 1.76089177 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 1.75580341 |
| 137 | Peritonitis (HP:0002586) | 1.74651119 |
| 138 | Epistaxis (HP:0000421) | 1.74362966 |
| 139 | Abnormal cartilage morphology (HP:0002763) | 1.73615144 |
| 140 | Acanthocytosis (HP:0001927) | 1.72562114 |
| 141 | Opisthotonus (HP:0002179) | 1.70279997 |
| 142 | Lymphangioma (HP:0100764) | 1.67999020 |
| 143 | Arthropathy (HP:0003040) | 1.64621880 |
| 144 | Abnormality of the pericardium (HP:0001697) | 1.64101604 |
| 145 | Elevated alkaline phosphatase (HP:0003155) | 1.63033322 |
| 146 | Skin rash (HP:0000988) | 1.60187835 |
| 147 | Chest pain (HP:0100749) | 1.58457706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 8.29721660 |
| 2 | ERN1 | 5.42372676 |
| 3 | BCKDK | 4.27268494 |
| 4 | TIE1 | 4.15254087 |
| 5 | RIPK4 | 3.82445035 |
| 6 | FGFR4 | 3.27963523 |
| 7 | IRAK4 | 3.22503906 |
| 8 | SIK1 | 2.84216187 |
| 9 | TNK2 | 2.45804898 |
| 10 | TGFBR2 | 2.43828702 |
| 11 | EPHB1 | 2.20483744 |
| 12 | TRIB3 | 2.19661731 |
| 13 | MST1R | 2.05085164 |
| 14 | FES | 1.94025503 |
| 15 | TAOK1 | 1.90844603 |
| 16 | TXK | 1.77576072 |
| 17 | TAOK3 | 1.74468493 |
| 18 | JAK1 | 1.67861843 |
| 19 | PTK6 | 1.65532143 |
| 20 | INSRR | 1.65211280 |
| 21 | DAPK2 | 1.62131432 |
| 22 | PKN2 | 1.56534143 |
| 23 | ERBB4 | 1.54459343 |
| 24 | TYK2 | 1.48211970 |
| 25 | JAK2 | 1.43890300 |
| 26 | RIPK1 | 1.42790752 |
| 27 | SYK | 1.39026424 |
| 28 | MAP2K3 | 1.31993401 |
| 29 | EPHA3 | 1.25260843 |
| 30 | MAP2K4 | 1.22646423 |
| 31 | FGR | 1.19415170 |
| 32 | MATK | 1.14492676 |
| 33 | IKBKB | 1.14411039 |
| 34 | MAPK11 | 1.10211293 |
| 35 | BLK | 1.09579832 |
| 36 | FLT3 | 1.08958500 |
| 37 | MAP3K11 | 1.03725703 |
| 38 | CAMK1D | 1.03665632 |
| 39 | MET | 1.02150839 |
| 40 | LCK | 1.00714722 |
| 41 | MAP3K3 | 0.99133921 |
| 42 | TGFBR1 | 0.97625471 |
| 43 | CSK | 0.97539962 |
| 44 | GRK1 | 0.96245172 |
| 45 | PRKD2 | 0.95753947 |
| 46 | TBK1 | 0.95013400 |
| 47 | JAK3 | 0.92301696 |
| 48 | CAMK4 | 0.92102887 |
| 49 | NEK9 | 0.91806726 |
| 50 | MAP3K2 | 0.87360283 |
| 51 | NLK | 0.84465272 |
| 52 | PTK2 | 0.82428806 |
| 53 | TLK1 | 0.81939683 |
| 54 | MAPK12 | 0.80481432 |
| 55 | KSR2 | 0.78909883 |
| 56 | ABL2 | 0.78476521 |
| 57 | YES1 | 0.78370125 |
| 58 | GRK6 | 0.78330029 |
| 59 | PIK3CG | 0.77917558 |
| 60 | TAOK2 | 0.77887018 |
| 61 | PRKAA2 | 0.77117747 |
| 62 | FGFR2 | 0.77113696 |
| 63 | MARK2 | 0.76041765 |
| 64 | SIK3 | 0.73756262 |
| 65 | MAP3K7 | 0.71138297 |
| 66 | ITK | 0.70817604 |
| 67 | SIK2 | 0.70593408 |
| 68 | FRK | 0.67986453 |
| 69 | LATS1 | 0.66881992 |
| 70 | MAPK15 | 0.65920324 |
| 71 | FGFR3 | 0.65876603 |
| 72 | MARK3 | 0.65427871 |
| 73 | MAPK4 | 0.65008822 |
| 74 | EPHB2 | 0.63448289 |
| 75 | PRKCQ | 0.63258594 |
| 76 | MAP4K1 | 0.62752477 |
| 77 | MAP2K1 | 0.61317446 |
| 78 | MAP3K1 | 0.59606679 |
| 79 | PRPF4B | 0.59324725 |
| 80 | FER | 0.58201207 |
| 81 | ADRBK2 | 0.58118233 |
| 82 | STK11 | 0.57642557 |
| 83 | ERBB2 | 0.57409418 |
| 84 | CAMK1G | 0.56674300 |
| 85 | MAP3K5 | 0.56497318 |
| 86 | HIPK2 | 0.56311572 |
| 87 | RET | 0.55159501 |
| 88 | GSK3A | 0.53640400 |
| 89 | EPHA2 | 0.52962412 |
| 90 | FYN | 0.52414631 |
| 91 | ZAP70 | 0.51663422 |
| 92 | MAP3K10 | 0.51130176 |
| 93 | IRAK2 | 0.51076779 |
| 94 | MAP3K13 | 0.51048919 |
| 95 | MAP3K14 | 0.50794607 |
| 96 | STK38 | 0.49878473 |
| 97 | IGF1R | 0.49820244 |
| 98 | CAMKK2 | 0.48082391 |
| 99 | GRK7 | 0.45884789 |
| 100 | EGFR | 0.45471475 |
| 101 | PTK2B | 0.45392475 |
| 102 | CHUK | 0.43528511 |
| 103 | PRKCZ | 0.43085422 |
| 104 | PDPK1 | 0.43074494 |
| 105 | PRKACG | 0.42727733 |
| 106 | RPS6KA6 | 0.42236105 |
| 107 | CDK6 | 0.42098797 |
| 108 | CDC42BPA | 0.41969837 |
| 109 | MAP2K2 | 0.41656137 |
| 110 | MAPKAPK2 | 0.40532288 |
| 111 | PRKCH | 0.40009035 |
| 112 | PIK3CA | 0.39738907 |
| 113 | MAP2K6 | 0.37847659 |
| 114 | IKBKE | 0.37593349 |
| 115 | BMPR2 | 0.36091762 |
| 116 | ADRBK1 | 0.35169830 |
| 117 | SMG1 | 0.35063858 |
| 118 | RPS6KC1 | 0.34904872 |
| 119 | IRAK3 | 0.34427332 |
| 120 | MYLK | 0.33926862 |
| 121 | BMX | 0.32467664 |
| 122 | LRRK2 | 0.31633953 |
| 123 | PRKAA1 | 0.30999906 |
| 124 | CSF1R | 0.30468983 |
| 125 | MAPK7 | 0.29937216 |
| 126 | TTN | 0.29537532 |
| 127 | PINK1 | 0.29292284 |
| 128 | SGK3 | 0.29034170 |
| 129 | CDK9 | 0.28619258 |
| 130 | BTK | 0.28304859 |
| 131 | PRKG2 | 0.27902483 |
| 132 | CAMK2G | 0.27830416 |
| 133 | DYRK1B | 0.21413820 |
| 134 | HCK | 0.20808701 |
| 135 | PDK1 | 0.20761189 |
| 136 | PRKCD | 0.19988728 |
| 137 | TEC | 0.19404729 |
| 138 | LYN | 0.18806519 |
| 139 | MAP3K6 | 0.18582704 |
| 140 | FGFR1 | 0.18188851 |
| 141 | IRAK1 | 0.18118416 |
| 142 | KIT | 0.18043558 |
| 143 | STK10 | 0.17811206 |
| 144 | PDGFRA | 0.17706130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.46246954 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.56950837 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44097652 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37571082 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.15906089 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.98473619 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.68777020 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52659435 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50953179 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45772499 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42998920 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36645225 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33449743 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.21888945 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.18072184 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.05545119 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00812632 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89236256 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88371672 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88203142 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88057624 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82599501 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71763095 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66668180 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64953465 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59231303 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58783657 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57258841 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55642055 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53691925 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.48371188 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46404458 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38665010 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37132779 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36011407 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.34448239 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33278331 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29488982 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26057562 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23303455 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23275623 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21836208 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21540679 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20457509 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18160306 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16312762 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14323750 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09551637 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96815203 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92981319 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92773675 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92087490 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88182144 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87986264 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82414970 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80963281 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80301287 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78977514 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.77829500 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77312574 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76680572 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76606646 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75289140 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.75082359 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72380870 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72131352 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.70762335 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69255567 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66204440 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66078690 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65959198 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64616971 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61502604 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.58725495 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57279974 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.56374941 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56011213 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52192111 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50631596 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50310105 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48981389 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46780250 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.46052183 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45809198 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45692311 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45515249 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.43560320 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43011909 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.43010029 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.42908953 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41641574 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40673943 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.40450175 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39122437 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37641117 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33947278 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32031647 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31659550 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29784357 |
| 100 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29637886 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29518773 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28796938 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28490966 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27683647 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27416689 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26418037 |
| 107 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.24224276 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23813760 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.22783738 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20559379 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19961346 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19397749 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.17112951 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15105463 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14172855 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09764628 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.04472534 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.01334371 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.01152167 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00427080 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | -4.2540764 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1268449 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1247235 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.1242808 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1217907 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.1180787 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1087700 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | -0.0810491 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0638449 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0624640 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0501788 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0262990 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0119474 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0040273 |

